New data could widen use of AstraZeneca, Amgen immune disease drug
Source ↗
👁 0
💬 0
Tezspire succeeded in a study in eosinophilic esophagitis, which could become the drug’s third approved indication and unlock what’s viewed as a blockbuster opportunity.
Comments (0)